GlucoCEST MRI for the early evaluation response to chemotherapeutic and metabolic treatments in a murine triple negative breast cancer: a comparison with 18F-FDG-PET.
M. Capozza, A. A. Anemone, C. Dhakan, M. Della Peruta, M. Bracesco, S. Zullino, D. Villano, E. Terreno, D. L. Longo, S. Aime
This paper compares glucoCEST MRI and 18F-FDG-PET for early metabolic response monitoring in a murine TNBC model, finding glucoCEST more sensitive to treatment effects.
bioRxiv · Mar 16, 2021Biophysics